Download presentation
Presentation is loading. Please wait.
Published byAubrie Butler Modified over 9 years ago
1
General Pathology Basic Principles of Cellular and Organ Pathology Oncology - I Jaroslava Dušková Inst. Pathol.,1st Med. Faculty, Charles Univ. Prague
2
General Oncology - 1 u Disorders of the cell proliferation and growth (hypertrophy, hyperplasia, metaplasia) u Neoplasms – disorders of cell proliferation and differentiation u Molecular biology of neoplasia - oncogenesis u Host - neoplasm interactions
3
Tumour swelling of any kind NEOPLASIA
4
Def.: persistent abnormal relatively autonomous proliferation of cells
5
NEOPLASIA – history I. Ramayana – 2000 B.C. v therapy with knife v chemotherapy arsenical compounds
6
NEOPLASIA – history II. Galen – AD 131–201 TUMOURS v according to nature pregnancy v exceeding nature inflammatory, reparative, callus v against nature true neoplasms
7
Growth Disturbances & Their Relation to Neoplasms
8
Nonneoplastic Growth Disturbances – I MALFORMATIONS v complete or partial lack of development (aplasia, hypoplasia) v asymmetry v oversize v hamartoma v choristoma v ectopic tissue - +
9
Hamartia – Hamartoma Def.: A mass of disorganized tissue indigenous to the particular site.
10
Choristia - Choristoma Def.: A mass of ectopic tissue (cells) with a limmited growth potency
11
Nonneoplastic Growth Disturbances – II v repair v hypertrophy / atrophy - (incl.pseudohypertrophy) v hyperplasia v metaplasia v dysplasia v anaplasia – undifferentiation
12
Nonneoplastic Growth Disturbances – II v repair v hypertrophy / atrophy - (incl.pseudohypertrophy) v hyperplasia v metaplasia v dysplasia v anaplasia – undifferentiation
13
Nonneoplastic Growth Disturbances – II v repair v hypertrophy / atrophy v hyperplasia v metaplasia v dysplasia v anaplasia – undifferentiation
14
Nonneoplastic Growth Disturbances – II v repair v hypertrophy / atrophy v hyperplasia v metaplasia v dysplasia v anaplasia – undifferentiation
15
Nonneoplastic Growth Disturbances – II v repair v hypertrophy / atrophy v hyperplasia v metaplasia v dysplasia v anaplasia – undifferentiation
16
Growth Disturbances to Neoplasms Relation 1. differential diagnosis pseudotumours 2. precursorsprecanceroses (preblastomatoses) 3. both 1. and 2.
17
NEOPLASIA Def.: persistent abnormal relatively autonomous proliferation of cells
18
Neoplasia (Tumour) v DNA disease v Stepwise accumulation of genetic abnormalities v Escape of immunological clearing systems
19
Neoplasia - causes External v Irradiation v chemical cancerogens v oncogenic viruses Internal immunosupression (inborn, acquired) chronic irritation (inflammation)
20
Oncogenic Viruses DNA u HPV u SV 40 – polyoma u Adenoviruses u Herpesviruses Epstein– Barr u Hepatitis B RNA u Rous sarcoma u Leukemia u HIV
21
Cell Cycle Regulators – control of cellular proliferation u polypeptide growth factors EGF, PDGF, FGF, TGFα, β (protooncogenes) u ligand receptor binding u activation via conformation alteration (kinase) u signal transduction – second messengers (tyrosine kinases) u activation of transcription factors u DNA synthesis initiation u cyclins and cyclin dependent kinases cdk u cdk associated inhibitors cki
22
Cell Cycle Regulators – growth factors Polypeptide growth stimulators u EGF, PDGF, TGF α (protooncogenes) u cytokins – IL-1, – TNF angiogenesis Polypeptide growth inhibitors u T(ransforming)GF β u interferon α u prostaglandin E-2
23
Cell Cycle Regulation Disorders – uncontroled cellular proliferation u polypeptide growth factors (e.g. EGF, PDGF, FGF,…) acting as oncogenes via overexpression u ligand receptor amplification u signal transducing proteins (e.g. ras oncoproteins) - activation othe mitogenic signaling pathway u nuclear DNA synthesis regulators (myc, jun, fos) u mitochondrial oncogenes (bcl-2) – prevention of apoptosis
24
Molecular Biological and Morphological Tumour Progression Normal cell Loss of growth control Loss of apoptosis control Loss of Senescence control Metastasising tumour cell dysplasia adenoma infiltrating carcinoma Molecular biological Morphological Tumour Progression genomic instability activation proteases
25
Host - Neoplasm Interactions immune surveillance immune response spontaneous regression local preassure cachexia anaemia immunodepression products of neoplastic cells
26
NEOPLASIA – function NEOPLASTIC CELL PRODUCTS: v immunoglobulin v osteiod v keratin v mucus v melanin v hormones
27
NEOPLASIA – function NEOPLASTIC CELL PRODUCTS: v immunoglobulin v osteiod v keratin v mucus v melanin v HORMONES
28
ENDOCRINE NEOPLASIA Hormone Production and Function v may or may not be present v unregulated – may be excessive v benign tumours more likely to be active v size of tumour not related to the degree of function v metastases may cause hyperfunction
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.